| Literature DB >> 23437265 |
Taketoshi Iwata1, Kazuhiro Chiku, Ken-Ichi Amano, Masahiro Kusumoto, Mayumi Ohnishi-Kameyama, Hiroshi Ono, Masato Akiba.
Abstract
Campylobacter jejuni is the most common bacterium that causes diarrhea worldwide, and chickens are considered the main reservoir of this pathogen. This study investigated the effects of serial truncation of lipooligosaccharide (LOS), a major component of the outer membrane of C. jejuni, on its bile resistance and intestinal colonization ability in chickens. Genes encoding manno-heptose synthetases or glycosyltransferases were inactivated to generate isogenic mutants. Serial truncation of the LOS core oligosaccharide caused a stepwise increase in susceptibilities of two C. jejuni strains, NCTC 11168 and 81-176, to bile acids. Inactivation of hldE, hldD, or waaC caused severe truncation of the core oligosaccharide, which greatly increased the susceptibility to bile acids. Both wild-type strains grew normally in chicken intestinal extracts, whereas the mutants with severe oligosaccharide truncation were not detected 12 h after inoculation. These mutants attained viable bacterial counts in the bile acid-free extracts 24 h after inoculation. The wild-type strain 11-164 was present in the cecal contents at >10(7) CFU/g on 5 days after challenge infection and after this time period, whereas its hldD mutant was present at <10(3) CFU/g throughout the experimental period. Trans-complementation of the hldD mutant with the wild-type hldD allele completely restored the in vivo colonization level to that of the wild-type strain. Mutants with a shorter LOS had higher hydrophobicities. Thus, the length of the LOS core oligosaccharide affected the surface hydrophobicity and bile resistance of C. jejuni as well as its ability to colonize chicken intestines.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23437265 PMCID: PMC3577681 DOI: 10.1371/journal.pone.0056900
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Plasmids and bacterial strains used in this study.
| Plasmid or strain | Description | Source or reference |
| Plasmids | ||
| pGem-T Easy | PCR cloning vector, Ampr | Promega |
| pUOA18 |
|
|
| pUOA18Km | pUOA18 modified to replace | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pUOA18Km- | pUOA18Km with | This study |
| pRK2013 | helper plasmid for triparental mating, Kmr |
|
| Strains | ||
|
| ||
| NCTC 11168 | Wild type; human isolate |
|
| 81-176 | Wild type; human isolate |
|
| 11-164 | Wild type; chicken isolate, Nalr | This study |
|
| ||
| 168gmhA | NCTC 11168 derivative; | This study |
| 168hldE | NCTC 11168 derivative; | This study |
| 168hldD | NCTC 11168 derivative; | This study |
| 168waaC | NCTC 11168 derivative; | This study |
| 168waaF | NCTC 11168 derivative; | This study |
| 168cj1135 | NCTC 11168 derivative; | This study |
| 168cj1136 | NCTC 11168 derivative; | This study |
| 168cj1138 | NCTC 11168 derivative; | This study |
| 168kpsS | NCTC 11168 derivative; | This study |
| 168hldEc | 168hldE/pUOA18Km- | This study |
| 168hldDc | 168hldD/pUOA18Km- | This study |
| 168waaCc | 168waaC/pUOA18Km- | This study |
| 168waaFc | 168waaF/pUOA18Km- | This study |
| 168cj1135c | 168cj1135/pUOA18Km- | This study |
| 168cj1136c | 168cj1136/pUOA18Km- | This study |
| 168cj1138c | 168cj1138/pUOA18Km- | This study |
| 817gmhA | 81-176 derivative; | This study |
| 817hldE | 81-176 derivative; | This study |
| 817hldD | 81-176 derivative; | This study |
| 817waaC | 81-176 derivative; | This study |
| 817waaF | 81-176 derivative; | This study |
| 817cjj1152 | 81-176 derivative; | This study |
| 817cjj1165 | 81-176 derivative; | This study |
| 817kpsS | NCTC 11168 derivative; | This study |
| 817hldEc | 817hldE/pUOA18Km- | This study |
| 817hldDc | 817hldD/pUOA18Km- | This study |
| 817waaCc | 817waaC/pUOA18Km- | This study |
| 817waaFc | 817waaF/pUOA18Km- | This study |
| 817cjj1152c | 817cjj1152/pUOA18Km- | This study |
| 817cjj1165c | 817cjj1165/pUOA18Km- | This study |
| 164hldE | 11-164 derivative; | This study |
| 164hldD | 11-164 derivative; | This study |
| 164waaC | 11-164 derivative; | This study |
| 164waaF | 11-164 derivative; | This study |
| 164hldDc | 164hldD/pUOA18Km- | This study |
|
| cloning strain | Takara |
Figure 1Hypothetical pathways of LOS biosynthesis in C. jejuni NCTC 11168 and 81-176.
The enzymes are indicated by arrow boxes. Abbreviations: GalNAc, N-acetylgalactosamine; Neu5Ac, N-acetylneuraminic acid; Gal, galactose; Glc, glucose; Hep, heptose; P/PEtn, phosphate or pyrophosphoethanolamine; Kdo, 2-keto-3-deoxy-d-manno-octulosonic acid.
Figure 2LOS profiles and LOS OS structures of the C. jejuni wild-type strains (NCTC 11168 and 81-176) and mutants.
(A) LOS samples were analyzed by tricine-SDS-PAGE using 16% tricine gels and visualized by silver staining. The positions of the protein size markers are indicated on the left of each panel. (B) The LOS structures of 168hldE, 168hldD, 168cj1135, 168cj1136, 168cj1138, 817hldE, and 817hldD were analyzed by MALDI-TOF MS and GC-MS in this study. The wild-type strains and other mutants with asterisks have structures similar to those determined in previous studies [24]–[26], [52]–[54]. Abbreviations, refer to the legend of Fig. 1.
Antimicrobial susceptibility of C. jejuni.
| Antimicrobial | MIC (µg/ml) | |||||||
| NCTC 11168 | 81-176 | |||||||
| Ia | IIa | IIIa | IVa | Ib | IIb | IIIb | IVb | |
| (wild-type, 168gmhA) | (168cj1136, 168cj1138) | (168waaF, 168cj1135) | (168hldE, 168hldD, 168waaC) | (wild-type, 817gmhA) | (817cjj1152, 817cjj1165) | (817waaF) | (817hldE, 817hldD, 817waaC) | |
|
| 25,000 | 25,000 | 25,000 | 6,250 | 12,500 | 12,500 | 6,250 | 6,250 |
|
| 12,500 | 12,500 | 12,500 | 3,130 | 6,250 | 6,250 | 3,130 | 3,130 |
|
| 6,250 | 3,130 | 3,130 | 1,560 | 3,130 | 3,130 | 780 | 780 |
|
| >10,000 | 10,000 | 5,000 | 313 | >10,000 | 10,000 | 625 | 313 |
|
| >100,000 | 100,000 | 100,000 | 12,500 | >100,000 | 100,000 | 12,500 | 12,500 |
|
| 100 | 100 | 100 | 50 | 50 | 50 | 25 | 25 |
| Ampicillin | >50 | >50 | >50 | >50 | 3.13 | 3.13 | 3.13 | 3.13 |
| Cefsulodin | 25 | 25 | 25 | 25 | 12.5 | 12.5 | 12.5 | 12.5 |
| Gentamicin | 0.313 | 0.313 | 0.313 | 0.313 | 0.313 | 0.313 | 0.313 | 0.313 |
| Tetracycline | <0.2 | <0.2 | <0.2 | <0.2 | 6.25 | 6.25 | 6.25 | 6.25 |
|
| 0.5 | 0.125 | 0.125 | 0.0625 | 0.125 | 0.125 | 0.0625 | 0.0313 |
| Trimethoprim | 500 | 500 | 500 | 500 | 250 | 250 | 250 | 250 |
| Nalidixic acid | 10 | 10 | 10 | 10 | 2.5 | 2.5 | 2.5 | 2.5 |
| Enrofloxacin | 0.0625 | 0.0625 | 0.0625 | 0.0625 | 0.0313 | 0.0313 | 0.0313 | 0.0313 |
|
| 200 | 200 | 200 | 100 | 100 | 100 | 50 | 50 |
|
| 5 | 2.5 | 2.5 | 2.5 | 2.5 | 1.25 | 1.25 | 1.25 |
Bold-faced types indicate that the differences in MICs observed between NCTC 11168 or 81-176 wild-type strain and any mutant.
The NCTC 11168 or 81-176 wild-type strain and mutants were divided into four groups (Ia–IVa or Ib–IVb) on the basis of MICs. The strains belonging to the same group showed identical MIC values for all of the antimicrobials tested.
Figure 3Growth of C. jejuni strains in chicken intestinal extracts.
C. jejuni NCTC 11168 wild-type strain and its mutants were grown in chicken jejunal extract (A), chicken ileal extract (B), chicken jejunal extract pretreated with cholestyramine (C), and chicken ileal extract pretreated with cholestyramine (D). C. jejuni 81-176 wild-type strain and its mutants were also grown in chicken jejunal extract (E), chicken ileal extract (F), chicken jejunal extract pretreated with cholestyramine (G), and chicken ileal extract pretreated with cholestyramine (H). Each point represents the mean value obtained from triplicate wells in 96-well microtiter plates. The detection limit for the assay was 0.4 log10 CFU/ml.
Figure 4Colonization of chickens by the C. jejuni 11-164 wild-type strain and its isogenic hldD mutant.
Each point represents the mean log10 CFU/g in the cecal contents of chickens in each group. Standard deviations are indicated by error bars. The dashed line indicates the lower limit of detection (0.7 log10 CFU/g).
Figure 5Effect of LOS truncations on the cell surface hydrophobicity of C. jejuni NCTC 11168 (A) and 81-176 (B).
The percentage hydrophobicity of the bacterial surface was calculated as follows: (1−final OD600 of the aqueous phase/initial OD600 of the cell suspension)×100. Standard deviations are indicated by error bars. *Significantly different from wild-type, **significant differences from both the wild-type and LOS mutants are labeled with an asterisk (P<0.05).